Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking.
- Authors
- Goldman, Steven A
- Year
- 2016
- Journal
- Cell stem cell
- PMID
- 26849304
- DOI
- 10.1016/j.stem.2016.01.012
- PMCID
- PMC5310249
A variety of neurological disorders are attractive targets for stem and progenitor cell-based therapy. Yet many conditions are not, whether by virtue of an inhospitable disease environment, poorly understood pathophysiology, or poor alignment of donor cell capabilities with patient needs. Moreover, some disorders may be medically feasible targets but are not practicable, in light of already available treatments, poor risk-benefit and cost-benefit profiles, or resource limitations. This Perspective seeks to define those neurological conditions most appropriate for cell replacement therapy by considering its potential efficacy and clinical feasibility in those disorders, as well as potential impediments to its application.
Neural and glial cell therapeutics and their disease targetsThis schematic illustrates the principal sources of transplantable human neural stem cells and phenotypically-restricted neuronal and glial progenitor cells, and highlights the most feasible current opportunities for their use in treating disorders of the brain.
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Using human stem cells as a model system to understand the neural mechanisms of alcohol use disorders: Current status and outlook. | 2019 | 30087005 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Engineering of rhesus monkey pluripotent stem cells for noninvasive survey and remote control after brain allotransplantation. | Cheng J et al. | — | 2026 | → |
| Lithocarpus litseifolius (Hance) Chun, widely known as sweet tea, promotes neuronal differentiation and maturation of neural stem/progenitor cells. | Jiang X et al. | — | 2026 | → |
| Unraveling the Morphological and Functional Maturation Mechanisms Underlying Human Neural Development Using iPSCs-Derived Neuronal Model. | Tian Y et al. | — | 2026 | → |
| Adult Neurogenesis in the Subventricular Zone of Patients with Huntington's and Parkinson's Diseases and following Long-Term Treatment with Deep Brain Stimulation. | Snapyan M et al. | — | 2025 | → |
| Bmi1 regulates neural differentiation of mesenchymal stem cells through the Wnt3a‑RhoA signaling pathway to repair ischemic brain injury in rats. | Chen K et al. | — | 2025 | → |
| Characteristic changes in astrocyte properties during astrocyte-to-neuron conversion induced by NeuroD1/Ascl1/Dlx2. | He Q et al. | — | 2025 | → |
| Human induced pluripotent stem cell-derived extracellular vesicles promote neuroprotection effects in rat optic nerve crush model. | Lu Y et al. | — | 2025 | → |
| Immune Cell-NSPC interactions: Friend or foe in CNS injury and repair? | Zeng CW | — | 2025 | → |
| Ngn2 and Isl1-mediated astrocyte-to-neuron conversion in vivo promotes functional recovery after spinal cord injury. | Zhou M et al. | — | 2025 | → |
| Oligodendroglia in Ageing and Age-Dependent Neurodegenerative Diseases. | Niu J et al. | — | 2025 | → |
| Small extracellular vesicles derived from human induced pluripotent stem cell-differentiated neural progenitor cells mitigate retinal ganglion cell degeneration in a mouse model of optic nerve injury. | Li T et al. | — | 2025 | → |
| A tumorigenicity evaluation platform for cell therapies based on brain organoids. | Xue J et al. | — | 2024 | → |
| Efficient Dlx2-mediated astrocyte-to-neuron conversion and inhibition of neuroinflammation by NeuroD1. | Liu MH et al. | — | 2024 | → |
| Exosomes in Vascular/Neurological Disorders and the Road Ahead. | Alzahrani FA et al. | — | 2024 | → |
| Extracellular Vesicles from Neural Stem Cells Carry microRNA-16-5p to Reduce Corticosterone-induced Neuronal Injury in Depression Rats. | Min XL et al. | — | 2024 | → |
| Glial-restricted progenitor cells: a cure for diseased brain? | Rogujski P et al. | — | 2024 | → |
| Human iPSC-derived neural stem cells displaying radial glia signature exhibit long-term safety in mice. | Luciani M et al. | — | 2024 | → |
| Injectable shear-thinning hydrogels promote oligodendrocyte progenitor cell survival and remyelination in the central nervous system. | Kumar Podder A et al. | — | 2024 | → |
| In situ direct reprogramming of astrocytes to neurons via polypyrimidine tract-binding protein 1 knockdown in a mouse model of ischemic stroke. | Yuan M et al. | — | 2024 | → |
| Ischemic and hemorrhagic stroke lesion environments differentially alter the glia repair potential of neural progenitor cell and immature astrocyte grafts. | Adewumi HO et al. | — | 2024 | → |
| Mining human clinical waste as a rich source of stem cells for neural regeneration. | Eivazi Zadeh Z et al. | — | 2024 | → |
| Neuronal conversion from glia to replenish the lost neurons. | Liang S et al. | — | 2024 | → |
| Two-photon live imaging of direct glia-to-neuron conversion in the mouse cortex. | Xiang Z et al. | — | 2024 | → |
| Astrocytes as master modulators of neural networks: Synaptic functions and disease-associated dysfunction of astrocytes. | Stogsdill JA et al. | — | 2023 | → |
| Developing Hypoimmunogenic Human iPSC-Derived Oligodendrocyte Progenitor Cells as an Off-The-Shelf Cell Therapy for Myelin Disorders. | Feng L et al. | — | 2023 | → |
| Efficient Generation of Dopaminergic Neurons from Mouse Ventral Midbrain Astrocytes. | Han JY et al. | — | 2023 | → |
| Gene expression and locomotor recovery in adult rats with spinal cord injury and plasma-synthesized polypyrrole/iodine application combined with a mixed rehabilitation scheme. | Coyoy-Salgado A et al. | — | 2023 | → |
| Human iPSC-derived neural stem cells display a radial glia-like signature<i>in vitro</i>and favorable long-term safety in transplanted mice | Luciani M et al. | — | 2023 | — |
| <i>In vivo</i> astrocyte-to-neuron reprogramming for central nervous system regeneration: a narrative review. | Talifu Z et al. | — | 2023 | → |
| Low-temperature 3D-printed collagen/chitosan scaffolds loaded with exosomes derived from neural stem cells pretreated with insulin growth factor-1 enhance neural regeneration after traumatic brain injury. | Liu XY et al. | — | 2023 | → |
| Mn-Based Methacrylated Gellan Gum Hydrogels for MRI-Guided Cell Delivery and Imaging. | Vieira S et al. | — | 2023 | → |
| The Ties That Bind: Glial Transplantation in White Matter Ischemia and Vascular Dementia. | Carmichael ST et al. | — | 2023 | → |
| What has single-cell transcriptomics taught us about long non-coding RNAs in the ventricular-subventricular zone? | Becker J et al. | — | 2023 | → |
| 2D Ti<sub>3</sub>C<sub>2</sub>T<sub>x</sub>MXene couples electrical stimulation to promote proliferation and neural differentiation of neural stem cells. | Guo R et al. | — | 2022 | → |
| Application of Small Molecules in the Central Nervous System Direct Neuronal Reprogramming. | Wang J et al. | — | 2022 | → |
| Gelatin methacrylate hydrogel loaded with brain-derived neurotrophic factor enhances small molecule-induced neurogenic differentiation of stem cells from apical papilla. | Zou T et al. | — | 2022 | → |
| Generation of a <i>NES</i>-mScarlet Red Fluorescent Reporter Human iPSC Line for Live Cell Imaging and Flow Cytometric Analysis and Sorting Using CRISPR-Cas9-Mediated Gene Editing. | Nouri P et al. | — | 2022 | → |
| In-vitro differentiation of human embryonic stem cells into spinal cord neural stem cells. | Chen X et al. | — | 2022 | → |
| Is Graphene Shortening the Path toward Spinal Cord Regeneration? | Girão AF et al. | — | 2022 | → |
| Monoclonal antibody-mediated immunosuppression enables long-term survival of transplanted human neural stem cells in mouse brain. | McGinley LM et al. | — | 2022 | → |
| Proteomic Analysis of Human Neural Stem Cell Differentiation by SWATH-MS. | Tyleckova J et al. | — | 2022 | → |
| Rapid differentiation of hiPSCs into functional oligodendrocytes using an OLIG2 synthetic modified messenger RNA. | Xu J et al. | — | 2022 | → |
| Small-molecule-driven direct reprogramming of Müller cells into bipolar-like cells. | Yang P et al. | — | 2022 | → |
| Stem cells from human exfoliated deciduous teeth affect mitochondria and reverse cognitive decline in a senescence-accelerated mouse prone 8 model. | Guo W et al. | — | 2022 | → |
| Stem Cell Therapy for Neuroprotection in the Growth-Restricted Newborn. | Chand K et al. | — | 2022 | → |
| The long-term survival and functional maturation of human iNPC-derived neurons in the basal forebrain of cynomolgus monkeys. | Feng S et al. | — | 2022 | → |
| The therapeutic prospects and challenges of human neural stem cells for the treatment of Alzheimer's Disease. | Yue C et al. | — | 2022 | → |
| TSG-6 released from adipose stem cells-derived small extracellular vesicle protects against spinal cord ischemia reperfusion injury by inhibiting endoplasmic reticulum stress. | Lu X et al. | — | 2022 | → |
| Commentary: <i>In vivo</i> Neuroregeneration to Treat Ischemic Stroke Through NeuroD1 AAV-Based Gene Therapy in Adult Non-human Primates. | Zhang X et al. | — | 2021 | → |
| Derivation of Oligodendrocyte Precursors from Adult Bone Marrow Stromal Cells for Remyelination Therapy. | Tsui YP et al. | — | 2021 | → |
| Donor cell memory confers a metastable state of directly converted cells. | Kim KP et al. | — | 2021 | → |
| Glial progenitor cell-based repair of the dysmyelinated brain: Progression to the clinic. | Goldman SA et al. | — | 2021 | → |
| Global Transcriptional Analyses of the Wnt-Induced Development of Neural Stem Cells from Human Pluripotent Stem Cells. | Liu BC et al. | — | 2021 | → |
| Human Neural Stem Cells for Cell-Based Medicinal Products. | Fernandez-Muñoz B et al. | — | 2021 | → |
| Hybrid SMART spheroids to enhance stem cell therapy for CNS injuries. | Rathnam C et al. | — | 2021 | → |
| Induced neural stem cells from human patient-derived fibroblasts attenuate neurodegeneration in Niemann-Pick type C mice. | Hong S et al. | — | 2021 | → |
| In vivo live imaging of postnatal neural stem cells. | Marymonchyk A et al. | — | 2021 | → |
| Microfluidics as efficient technology for the isolation and characterization of stem cells. | Aghlmandi A et al. | — | 2021 | → |
| Oligodendrocyte Development and Implication in Perinatal White Matter Injury. | Motavaf M et al. | — | 2021 | → |
| Reliable generation of glial enriched progenitors from human fibroblast-derived iPSCs. | Llorente IL et al. | — | 2021 | → |
| Reprogramming Glial Cells into Functional Neurons for Neuro-regeneration: Challenges and Promise. | Wang F et al. | — | 2021 | → |
| Salidroside-pretreated mesenchymal stem cells contribute to neuroprotection in cerebral ischemic injury in vitro and in vivo. | Zhou L et al. | — | 2021 | → |
| A NeuroD1 AAV-Based Gene Therapy for Functional Brain Repair after Ischemic Injury through In Vivo Astrocyte-to-Neuron Conversion. | Chen YC et al. | — | 2020 | → |
| A scoping review of trials for cell-based therapies in human spinal cord injury. | Willison AG et al. | — | 2020 | → |
| Assessment of Ethanol-Induced Toxicity on iPSC-Derived Human Neurons Using a Novel High-Throughput Mitochondrial Neuronal Health (MNH) Assay. | Zink A et al. | — | 2020 | → |
| Cell-Based Therapy for Canavan Disease Using Human iPSC-Derived NPCs and OPCs. | Feng L et al. | — | 2020 | → |
| Decoding epigenetic codes: new frontiers in exploring recovery from spinal cord injury. | Zhang BY et al. | — | 2020 | → |
| Developmental dynamics of neurogenesis and gliogenesis in the postnatal mammalian brain in health and disease: Historical and future perspectives. | Nakafuku M et al. | — | 2020 | → |
| Differential neuronal reprogramming induced by NeuroD1 from astrocytes in grey matter <i>versus</i> white matter. | Liu MH et al. | — | 2020 | → |
| Extracellular vesicle-mediated transfer of miR-21-5p from mesenchymal stromal cells to neurons alleviates early brain injury to improve cognitive function via the PTEN/Akt pathway after subarachnoid hemorrhage. | Gao X et al. | — | 2020 | → |
| Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington's disease. | Wu Z et al. | — | 2020 | → |
| HGF Mediates Clinical-Grade Human Umbilical Cord-Derived Mesenchymal Stem Cells Improved Functional Recovery in a Senescence-Accelerated Mouse Model of Alzheimer's Disease. | Jia Y et al. | — | 2020 | → |
| High-throughput 3D screening for differentiation of hPSC-derived cell therapy candidates. | Muckom R et al. | — | 2020 | → |
| Human Glial Progenitor Cells Effectively Remyelinate the Demyelinated Adult Brain. | Windrem MS et al. | — | 2020 | → |
| Human Pluripotent Stem Cell-Derived Neurons Are Functionally Mature In Vitro and Integrate into the Mouse Striatum Following Transplantation. | Comella-Bolla A et al. | — | 2020 | → |
| <i>In vivo</i> Neuroregeneration to Treat Ischemic Stroke Through NeuroD1 AAV-Based Gene Therapy in Adult Non-human Primates. | Ge LJ et al. | — | 2020 | → |
| Novel therapeutic strategies for Alzheimer's disease: Implications from cell-based therapy and nanotherapy. | Derakhshankhah H et al. | — | 2020 | → |
| Recent Advances in Stem Cell Research in Subarachnoid Hemorrhage. | Song Z et al. | — | 2020 | → |
| Regeneration of Functional Neurons After Spinal Cord Injury via <i>in situ</i> NeuroD1-Mediated Astrocyte-to-Neuron Conversion. | Puls B et al. | — | 2020 | → |
| Stem cell homing, tracking and therapeutic efficiency evaluation for stroke treatment using nanoparticles: A systematic review. | Nucci MP et al. | — | 2020 | → |
| Stereoselective Total Synthesis of (±)-Alstoscholarisine E. | Wood MD et al. | — | 2020 | → |
| TNF-α Pretreatment Improves the Survival and Function of Transplanted Human Neural Progenitor Cells Following Hypoxic-Ischemic Brain Injury. | Kim M et al. | — | 2020 | → |
| Catalpol Enhances Neurogenesis And Inhibits Apoptosis Of New Neurons Via BDNF, But Not The BDNF/Trkb Pathway. | Zhu HF et al. | — | 2019 | → |
| Evaluation of Neurosecretome from Mesenchymal Stem Cells Encapsulated in Silk Fibroin Hydrogels. | Martín-Martín Y et al. | — | 2019 | → |
| Glial Cell Line-derived Neurotrophic Factor-overexpressing Human Neural Stem/Progenitor Cells Enhance Therapeutic Efficiency in Rat with Traumatic Spinal Cord Injury. | Hwang K et al. | — | 2019 | → |
| Human Glial Chimeric Mice to Define the Role of Glial Pathology in Human Disease. | Mariani JN et al. | — | 2019 | → |
| Induction of immunological tolerance to myelinogenic glial-restricted progenitor allografts. | Li S et al. | — | 2019 | → |
| Intrahippocampal Transplantation of Undifferentiated Human Chorionic- Derived Mesenchymal Stem Cells Does Not Improve Learning and Memory in the Rat Model of Sporadic Alzheimer Disease. | Mohammadi A et al. | — | 2019 | → |
| Large-Scale Generation and Characterization of Homogeneous Populations of Migratory Cortical Interneurons from Human Pluripotent Stem Cells. | Ni P et al. | — | 2019 | → |
| Long-Term Safety, Immunologic Response, and Imaging Outcomes following Neural Stem Cell Transplantation for Pelizaeus-Merzbacher Disease. | Gupta N et al. | — | 2019 | → |
| Monitoring maturation of neural stem cell grafts within a host microenvironment. | Kopach O | — | 2019 | → |
| Neuronal Transdifferentiation Potential of Human Mesenchymal Stem Cells from Neonatal and Adult Sources by a Small Molecule Cocktail. | Cortés-Medina LV et al. | — | 2019 | → |
| Non-engineered and Engineered Adult Neurogenesis in Mammalian Brains. | Lei W et al. | — | 2019 | → |
| Non-proliferative neurogenesis in human periodontal ligament stem cells. | Bueno C et al. | — | 2019 | → |
| Reduction of Inflammation and Enhancement of Motility after Pancreatic Islet Derived Stem Cell Transplantation Following Spinal Cord Injury. | Karaoz E et al. | — | 2019 | → |
| Reprogramming of Fibroblasts to Oligodendrocyte Progenitor-like Cells Using CRISPR/Cas9-Based Synthetic Transcription Factors. | Matjusaitis M et al. | — | 2019 | → |
| RNA-silencing nanoprobes for effective activation and dynamic imaging of neural stem cell differentiation. | Zhang R et al. | — | 2019 | → |
| Roles of mTOR Signaling in Tissue Regeneration. | Wei X et al. | — | 2019 | → |
| Stem cell transplantation for ischemic stroke. | Boncoraglio GB et al. | — | 2019 | → |
| The Expression and Functional Roles of miRNAs in Embryonic and Lineage-Specific Stem Cells. | Farzaneh M et al. | — | 2019 | → |
| The neurorestorative effect of human amniotic fluid stem cells on the chronic phase of neonatal hypoxic-ischemic encephalopathy in mice. | Otani T et al. | — | 2019 | → |
| TIGAR promotes neural stem cell differentiation through acetyl-CoA-mediated histone acetylation. | Zhou W et al. | — | 2019 | → |
| Transplantation of Human Chorion-Derived Cholinergic Progenitor Cells: a Novel Treatment for Neurological Disorders. | Mohammadi A et al. | — | 2019 | → |
| Using human stem cells as a model system to understand the neural mechanisms of alcohol use disorders: Current status and outlook. | Scarnati MS et al. | — | 2019 | → |
| A Nestin-Cyclin-Dependent Kinase 5-Dynamin-Related Protein 1 Axis Regulates Neural Stem/Progenitor Cell Stemness via a Metabolic Shift. | Wang J et al. | — | 2018 | → |
| Brain and spinal cord injury repair by implantation of human neural progenitor cells seeded onto polymer scaffolds. | Shin JE et al. | — | 2018 | → |
| Cografting astrocytes improves cell therapeutic outcomes in a Parkinson's disease model. | Song JJ et al. | — | 2018 | → |
| Cold Atmospheric Plasmas: A Novel and Promising Way to Treat Neurological Diseases. | Xiong Z | — | 2018 | → |
| Customized Brain Cells for Stroke Patients Using Pluripotent Stem Cells. | Kokaia Z et al. | — | 2018 | → |
| Developmentally primed cortical neurons maintain fidelity of differentiation and establish appropriate functional connectivity after transplantation. | Wuttke TV et al. | — | 2018 | → |
| Generation and post-injury integration of human spinal cord neural stem cells. | Kumamaru H et al. | — | 2018 | → |
| Human Pluripotent Stem-Cell-Derived Cortical Neurons Integrate Functionally into the Lesioned Adult Murine Visual Cortex in an Area-Specific Way. | Espuny-Camacho I et al. | — | 2018 | → |
| Hydrogels-Assisted Cell Engraftment for Repairing the Stroke-Damaged Brain: Chimera or Reality. | González-Nieto D et al. | — | 2018 | → |
| Lymphotoxin β receptor-mediated NFκB signaling promotes glial lineage differentiation and inhibits neuronal lineage differentiation in mouse brain neural stem/progenitor cells. | Xiao X et al. | — | 2018 | → |
| Manipulable Permeability of Nanogel Encapsulation on Cells Exerts Protective Effect against TNF-α-Induced Apoptosis. | Li W et al. | — | 2018 | → |
| Mechanisms underlying dental-derived stem cell-mediated neurorestoration in neurodegenerative disorders. | Raza SS et al. | — | 2018 | → |
| Nanomaterials in Neural-Stem-Cell-Mediated Regenerative Medicine: Imaging and Treatment of Neurological Diseases. | Zhang B et al. | — | 2018 | → |
| Nano-structural analysis of engrafted human induced pluripotent stem cell-derived cardiomyocytes in mouse hearts using a genetic-probe APEX2. | Hatani T et al. | — | 2018 | → |
| Neural stem cell derived extracellular vesicles: Attributes and prospects for treating neurodegenerative disorders. | Vogel AD et al. | — | 2018 | → |
| Possible Role of PHD Inhibitors as Hypoxia-Mimicking Agents in the Maintenance of Neural Stem Cells' Self-Renewal Properties. | Wu LY et al. | — | 2018 | → |
| PTB/nPTB: master regulators of neuronal fate in mammals. | Hu J et al. | — | 2018 | → |
| Reprogramming Glia Into Neurons in the Peripheral Auditory System as a Solution for Sensorineural Hearing Loss: Lessons From the Central Nervous System. | Meas SJ et al. | — | 2018 | → |
| Stem-Cell Therapy Advances in China. | Hu L et al. | — | 2018 | → |
| Targeting Alzheimer's disease with gene and cell therapies. | Loera-Valencia R et al. | — | 2018 | → |
| Transplanted neural progenitors bridge gaps to benefit cord-injured monkeys. | Goldman SA | — | 2018 | → |
| BMP4/LIF or RA/Forskolin Suppresses the Proliferation of Neural Stem Cells Derived from Adult Monkey Brain. | Han X et al. | — | 2017 | → |
| Brain repair from intrinsic cell sources: Turning reactive glia into neurons. | Torper O et al. | — | 2017 | → |
| Direct Generation of Human Neuronal Cells from Adult Astrocytes by Small Molecules. | Gao L et al. | — | 2017 | → |
| Direct Neuronal Reprogramming: Achievements, Hurdles, and New Roads to Success. | Gascón S et al. | — | 2017 | → |
| High Yield of Adult Oligodendrocyte Lineage Cells Obtained from Meningeal Biopsy. | Dolci S et al. | — | 2017 | → |
| Human astrocytes are distinct contributors to the complexity of synaptic function. | Krencik R et al. | — | 2017 | → |
| Induced neural stem cells modulate microglia activation states via CXCL12/CXCR4 signaling. | Gao M et al. | — | 2017 | → |
| Perspective: Neuroregenerative Nutrition. | Steindler DA et al. | — | 2017 | → |
| Regulation of adult neural progenitor cell functions by purinergic signaling. | Tang Y et al. | — | 2017 | → |
| Systematic Three-Dimensional Coculture Rapidly Recapitulates Interactions between Human Neurons and Astrocytes. | Krencik R et al. | — | 2017 | → |
| The use of mesenchymal stem cells (MSCs) for amyotrophic lateral sclerosis (ALS) therapy - a perspective on cell biological mechanisms. | Tang BL | — | 2017 | → |
| 3K3A-activated protein C stimulates postischemic neuronal repair by human neural stem cells in mice. | Wang Y et al. | — | 2016 | → |
| Cellular identity at the single-cell level. | Coskun AF et al. | — | 2016 | → |
| Comparison of MSC-Neurogenin1 administration modality in MCAO rat model. | Shin DH et al. | — | 2016 | → |
| Current Understanding of the Pathways Involved in Adult Stem and Progenitor Cell Migration for Tissue Homeostasis and Repair. | Goichberg P | — | 2016 | → |
| Glial progenitor cell-based treatment of the childhood leukodystrophies. | Osorio MJ et al. | — | 2016 | → |
| Induced Pluripotent Stem Cells in Huntington's Disease Research: Progress and Opportunity. | Tousley A et al. | — | 2016 | → |
| In Vivo Reprogramming for CNS Repair: Regenerating Neurons from Endogenous Glial Cells. | Li H et al. | — | 2016 | → |
| Tumor prevention facilitates delayed transplant of stem cell-derived motoneurons. | Magown P et al. | — | 2016 | → |